CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,523 | +352.3% | 100 | +1150.0% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 8 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | -99.4% | 8 | -99.5% | 0.00% | -100.0% |
Q3 2021 | $169,000 | -31.3% | 1,508 | -0.8% | 0.03% | -38.1% |
Q2 2021 | $246,000 | +303.3% | 1,520 | +204.0% | 0.04% | +61.5% |
Q1 2021 | $61,000 | -80.2% | 500 | -75.2% | 0.03% | -81.2% |
Q4 2020 | $308,000 | +30700.0% | 2,015 | +13333.3% | 0.14% | – |
Q3 2020 | $1,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | – | 15 | +200.0% | 0.00% | – |
Q4 2019 | $0 | – | 5 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 5 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 5 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |